Universal Orphan Drug Market- Current Market & Growth

1
Global Orphan Drug Pipeline Analysis
Published Date December 2013
No. of Pages 1690
Price Single User US2400
Corporate User US4200
2
New Market Research Report on Global Orphan Drug
Pipeline Analysis added to ReportsnReports.com
In recent years, the pharmaceutical industry has
been experiencing a paradigm shift. While a large
pool of patients was considered as a major source
of revenue for pharma companies in the past, the
focus is now gradually shifting to small sections
of patients suffering from rare disease. In US
Europe, this pool of patients is gradually
growing and Orphan Drugs are becoming an
extremely attractive business proposition for the
pharmaceuticals industry. With close to 65-70
Million people in the US Europe having some
kind of rare disease complaints, the increasing
activities around the development of orphan drugs
only imply that the appropriate treatments for
unmet needs are increasing, thus increasing the
profit margins in the future. As the Asian
pharmaceutical markets are still in growth stage,
the opportunities for orphan drugs in Asia are
also immense and getting increasingly popular. It
is expected that by 2020, the Asian orphan drugs
market would witness steady growth. Global
Orphan Drug Pipeline Analysis by PNS Pharma
gives comprehensive insight on the various orphan
designated drugs being developed for the
treatment of rare disease. Research report covers
all the orphan designated drugs being developed
in various development phases. This report
enables pharmaceutical companies, collaborators
and other associated stake holders to identify
and analyze the available investment opportunity
in the Orphan Drug market based upon development
process.
3
Global Orphan Drug Pipeline Analysis
Following parameters for each orphan designated
drug profile in development phase are covered in
Global Orphan Drug Pipeline Analysis research
report Drug Profile Overview Alternate Names for
Drug Active Indication Phase of
Development Mechanism of Action Brand Name Patent
Information Orphan Designation by Indication,
Country Organisation Country for Clinical
Trial Owner / Originator/ Licensee/Collaborator Ad
ministrative Route Drug Class ATC Codes Buy a
copy of this report _at_ http//www.reportsnreports.c
om/purchase.aspx?name271801 .
Browse more research reports on Pharmaceuticals _at_
http//www.reportsnreports.com/market-research/pha
rmaceuticals/ .
4
Global Orphan Drug Pipeline Analysis
Global Orphan Drug Pipeline by Clinical
Phase Research 3 Preclinical 71 Clinical
4 Phase-I 61 Phase-I/II 71 Phase-II
198 Phase-II/III 20 Phase-III
103 Preregistration 26 Registration
17 Marketed 244 Unknown 1 Table of Contents 1.
Global Orphan Drugs Market Overview 2. Orphan
Drug Clinical Development Phase Unknown2.1
Overview2.2 Orphan Drug Profile in Clinical
Phase Buy a copy of this report _at_
http//www.reportsnreports.com/purchase.aspx?name
271801 .
5
Global Orphan Drug Pipeline Analysis
3. Orphan Drug Clinical Development Phase
Research3.1 Overview3.2 Orphan Drug Profile in
Clinical Phase 4. Orphan Drug Clinical
Development Phase Preclinical4.1 Overview4.2
Orphan Drug Profile in Clinical Phase 5. Orphan
Drug Clinical Drug Development Phase
Clinical5.1 Overview5.2 Orphan Drug Profile in
Clinical Phase 6. Orphan Drug Clinical
Development Phase Phase-I6.1 Overview6.2
Orphan Drug Profile in Clinical Phase 7. Orphan
Drug Clinical Development Phase Phase-I/II7.1
Overview7.2 Orphan Drug Profile in Clinical
Phase
Browse more research reports on Pharmaceuticals _at_
http//www.reportsnreports.com/market-research/pha
rmaceuticals/ .
6
Global Orphan Drug Pipeline Analysis
8. Orphan Drug Clinical Development Phase
Phase-II8.1 Overview8.2 Orphan Drug Profile in
Clinical Phase 9. Orphan Drug Clinical
Development Phase Phase-II/III9.1 Overview9.2
Orphan Drug Profile in Clinical Phase 10. Orphan
Drug Clinical Development Phase Phase-III10.1
Overview10.2 Orphan Drug Profile in Clinical
Phase 11. Orphan Drug Clinical Development Phase
Pre-Registration11.1 Overview11.2 Orphan Drug
Profile in Clinical Phase 12. Orphan Drug
Clinical Development Phase Registered12.1
Overview12.2 Orphan Drug Profile in Clinical
Phase Buy a copy of this report _at_
http//www.reportsnreports.com/purchase.aspx?name
271801 .
7
Global Orphan Drug Pipeline Analysis
13. Marketed Orphan Drug13.1 Overview13.2Markete
d Orphan Drug Profiles You can also reach us _at_
http//pharmaceuticalsindustryreports.blogspot.in/
.
Browse more research reports on Pharmaceuticals _at_
http//www.reportsnreports.com/market-research/pha
rmaceuticals/ .
8
About ReportsnReports
ReportsnReports.com is your single source for all
market research needs. Our database includes
250,000 syndicated market research reports from
100 leading global publishers covering in-depth
analysis of over 5000 micro markets. With
comprehensive information about the publishers
and their report methodology, data sources, etc.
we help you in your purchase decision by mapping
your information needs with the most relevant
available reports in our library. Connect with
us sales_at_reportsandreports.com 1 888 391 5441
Contact sales_at_reportsandreports.com for further
information.
Contact sales_at_reportsandreports.com for further
information.